Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

Market Cap	7.90B -1.7%
Revenue (ttm)	3.29B -15.5%
Net Income	303.93M -22.4%
EPS	0.54 -20.6%
Shares Out	566.16M
PE Ratio	25.83
Forward PE	22.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,435,200
Average Volume	5,555,047
Open	13.91
Previous Close	13.93
Day's Range	13.87 - 14.06
52-Week Range	12.55 - 20.20
Beta	0.60
RSI	48.82
Earnings Date	Apr 23, 2026

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1975
• Employees: 6,132
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600557

Financial Performance

In 2025, SHA:600557's revenue was 3.29 billion, a decrease of -15.52% compared to the previous year's 3.90 billion. Earnings were 303.93 million, a decrease of -22.44%.